spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:   Alcon 

 HSMN NewsFeed - 14 Jul 2026
Zimmer Biomet Names Chintan Desai President of Asia Pacific Region
Devices Orthopaedic Personnel
 HSMN NewsFeed - 1 Apr 2026
Nanoscope Therapeutics Appoints Ophthalmology Industry Veteran Paul Hallen as Chief Operating Officer to Advance Global Commercial Readiness
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 29 Mar 2023
Spiral Therapeutics Acquires Otonomy Assets to Boost Inner Ear Disorders Pipeline and Appoints Industry Leaders to Board
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 12 Jan 2023
Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Apr 2022
Nanoscope Therapeutics Appoints Pharma Industry Veteran Aaron Osborne, MBBS, as Chief Medical Officer and Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Nov 2021
Medtronic Taps Top Digital and Healthcare Technology Leaders to Drive Company Transformation
Devices Personnel
 HSMN NewsFeed - 23 Feb 2021
PYC Therapeutics Expands U.S. Executive Leadership Team with the Appointment of Glenn Noronha, PhD, as Chief Development Officer
Biopharmaceutical Drug Delivery Personnel
 HSMN NewsFeed - 10 Aug 2020
Sight Sciences Announces First Patients Enrolled in ORION: A Prospective, Multicenter Clinical Trial of the OMNI Surgical System in Pseudophakic, Mild-to-Moderate Glaucoma Patients
Devices Ophthalmology
 HSMN NewsFeed - 7 May 2020
Sight Sciences Introduces the Next-Generation OMNI(R) Surgical System for Microinvasive Glaucoma Surgery
Devices Ophthalmology Product Launch
 HSMN NewsFeed - 9 Dec 2019
Sight Sciences Appoints Erica Rogers to its Board of Directors
Devices Ophthalmology Personnel
 HSMN NewsFeed - 22 Oct 2019
International MIGS Study Confirms Long-Term Safety and Efficacy of the OMNI(R) Surgical System Predicate Device (VISCO360(R))
Devices Ophthalmology
 HSMN NewsFeed - 22 Aug 2019
Erasca Announces Key Leadership Team Appointments and Recruits World-Class Research and Development Advisory Board
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 25 Apr 2019
DURECT Appoints Two New Board Members
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 14 Mar 2019
Clinical Study Demonstrates Long Term IOP Reduction with the OMNI(R) Surgical System Predicate Device (TRAB(R)360) in Micro-Invasive Glaucoma Surgery
Devices Ophthalmology
 HSMN NewsFeed - 20 Nov 2018
Oculis Strengthens its Global Clinical and Business Development Capabilities Through Strategic Appointments to Senior Management Team
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 4 Oct 2018
Launch of The 4Klear(TM), Native 4K Surgical Microscope Camera with integrated 4K Recording
Devices Surgery Product Launch
 HSMN NewsFeed - 24 Sep 2018
Oculis Appoints World-renowned Ophthalmology Specialist
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 20 Jul 2018
Alcon introduces NGENUITY(R) 3D Visualization System with DATAFUSION(TM) to simplify, customize vitreoretinal surgery
Devices Ophthalmology Surgery Product Launch
 HSMN NewsFeed - 14 Mar 2018
Sight Sciences Names Jesse Selnick Chief Financial Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 4 Jan 2018
Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 12 Dec 2017
Eyevensys Appoints Dr. Patricia Zilliox as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 9 Oct 2017
Sight Sciences Secures $10MM in Oversubscribed Series C Financing
Devices Ophthalmology Venture Capital Personnel
 HSMN NewsFeed - 23 Dec 2016
Alcon receives US FDA approval for AcrySof(R) IQ ReSTOR(R) +3.0D Multifocal Toric intraocular lens for cataract patients
Devices Ophthalmology FDA
 HSMN NewsFeed - 6 Oct 2016
Novaliq Strengthens Executive Management Team by Appointing Christian Roesky, PhD, as Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 28 Jun 2016
iSTAR Medical Strengthens Board With Two Senior Appointments
Devices Ophthalmology Personnel
 HSMN NewsFeed - 12 Jan 2016
ZELTIQ Announces Executive Leadership Addition and Global Commercial Operations Realignment
Devices Dermatology Personnel
 HSMN NewsFeed - 21 Oct 2015
Allegro Ophthalmics Names Scott Cooper as Chief Financial Officer and Vice President of Business Development and Mohamed Genead, MD, as Executive Medical Director
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 5 Aug 2015
Ohr Pharmaceutical Promotes Jason S. Slakter, MD to Chief Executive Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 20 Jan 2015
NovaBay Expands Sales Force for Avenova
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 14 May 2014
Avedro Welcomes Robert J. Palmisano to its Board of Directors
Devices Ophthalmology Personnel
 HSMN NewsFeed - 4 Mar 2014
ThromboGenics Initiates Major Post-Marketing Patient Trial with JETREA(R) in the US
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 3 Dec 2013
J-Code for ThromboGenics' JETREA to Become Effective January 1, 2014
Biopharmaceuticals Ophthalmology Reimbursement
 HSMN NewsFeed - 5 Sep 2013
ThromboGenics Acquires Exclusive Rights from Bicycle Therapeutics to Develop and Commercialize Novel Drugs Inhibiting a Target for Diabetic Macular Edema
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 2 Sep 2013
UK's NICE Final Appraisal Determination (FAD) Confirms Positive Recommendation for ThromboGenics' JETREA(R) for Treatment of Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology Regulatory Reimbursement
 HSMN NewsFeed - 2 Aug 2013
Germany's IQWiG Confirms That ThromboGenics' JETREA(R) Demonstrates Major Added Value for the Treatment of Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 30 Jul 2013
Andrea L. Saia Joins Align Technology Board of Directors
Devices Dental Personnel
 HSMN NewsFeed - 23 Jul 2013
BIOLASE Names Medical Device Marketing Veteran Orlando Rodrigues as Vice President, Marketing
Devices Dental Personnel
 HSMN NewsFeed - 26 Jun 2013
Middle Peak Medical Raises $8.5 M to Develop Novel Mitral Valve Technology
Devices Cardiology Venture Capital
 HSMN NewsFeed - 12 Jun 2013
ThromboGenics' JETREA(R) Receives Positive Initial NICE Recommendation for Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 18 Jan 2013
ThromboGenics Receives Positive CHMP Opinion for JETREA(R)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 4 Jan 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 27 Dec 2012
John Norris, JD, MBA Appointed CEO of Health Discovery Corporation
Diagnostics Personnel Personalized Medicine
 HSMN NewsFeed - 17 Dec 2012
Andrew Technologies Receives FDA 510(k) Clearance for Commercial Version of HydraSolve(TM) Lipoplasty System
Devices Surgery FDA
 HSMN NewsFeed - 20 Nov 2012
SensoMotoric Instruments (SMI) sells Ophthalmic Division to Alcon
Devices Ophthalmology Acquisitions
 HSMN NewsFeed - 18 Oct 2012
U.S. FDA Approves ThromboGenics' JETREA(R) (Ocriplasmin) for the Treatment of Symptomatic Vitreomacular Adhesion (VMA)
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 1 Oct 2012
Restoration Robotics, Inc. Appoints New Board Member
Devices Personnel
 HSMN NewsFeed - 20 Jun 2012
Sucampo Appoints Dipak Panigrahi, MS, MD, as Vice President, Medical Affairs
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 May 2012
New HydraSolve(TM) Lipoplasty System launched at American Society of Aesthetic Plastic Surgery Meeting
Devices Surgery
 HSMN NewsFeed - 17 Apr 2012
ThromboGenics Resubmits BLA for Ocriplasmin With the FDA
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 16 Mar 2012
ThromboGenics Enters Into Commercialization Agreement for Ocriplasmin With Alcon Outside the United States
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 10 Jan 2012
Interwest Partners Expands Medical Devices Team
Devices Venture Capital Personnel
 HSMN NewsFeed - 4 Oct 2011
NovaBay Pharmaceuticals Names David W. Stroman, Ph.D. as Head of Ophthalmic Drug Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Sep 2011
Wright Medical Group, Inc. Names Robert J. Palmisano President and Chief Executive Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 16 Jun 2011
NovaBay Regains Worldwide Rights to Its Aganocide Compounds From Alcon
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Apr 2011
Novartis Therapy Gilenya Reduced the Risk of MS Disability Progression Regardless of Treatment History or Disease Severity, New Analysis Shows
Biopharmaceuticals Neurology
 HSMN NewsFeed - 3 Feb 2011
Otonomy Adds Key Product and Industry Experience with Appointment of New Vice Presidents
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2010
Alcon and Novartis Agree to Merger Terms
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 12 Nov 2010
Delenex Therapeutics Secures CHF 13.5 Million Series A Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Oct 2010
NovaBay Pharmaceuticals Appoints Gail Maderis, BayBio President and CEO and Former Genzyme Senior Executive, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2010
STAAR Surgical Launches New Visian ICL Product Line Extensions at ESCRS
Devices Ophthalmology
 HSMN NewsFeed - 3 Sep 2010
Alcon Launches AcrySof(R) IQ ReSTOR(R) Toric Intraocular Lens Outside the United States
Devices Ophthalmology
 HSMN NewsFeed - 26 Aug 2010
Celgene Corporation Announces Appointment of Jacqualyn A. Fouse as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2010
QLT Names Dipak Panigrahi, M.D., as Chief Medical Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 14 Jan 2010
STAAR Surgical Names Don Fagen Vice President of Sales, North America
Devices Ophthalomology Personnel
 HSMN NewsFeed - 19 Oct 2009
NovaBay Pharmaceuticals Expands Management Team; Names Mark Anderson, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Aug 2009
NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Jul 2009
Alcon Discontinues Development of Anecortave Acetate for Intraocular Pressure Reduction
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 25 Mar 2009
NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBay's Novel Aganocide Drugs for Major Dermatological Conditions
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 20 Jan 2009
NovaBay (NBY) Appoints Harry F. Hixson, Jr., PhD, Former Amgen President/Chief Operating Officer to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2008
Alcon Launches New AcrySof(R) ReSTOR(R) Intraocular Lens for Presbyopia Outside the U.S.
Devices Ophthalmology
 HSMN NewsFeed - 12 Sep 2008
Alcon Expands Refractive Surgery Options with the Introduction of the AcrySof(R) Phakic Intraocular Lens Outside the U.S.
Devices Ophthalmology
 HSMN NewsFeed - 11 Jul 2008
Alcon Terminates the Development of Anecortave Acetate in Age-Related Macular Degeneration
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Jul 2008
Novartis Completes Purchase of Minority Interest in Alcon
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 8 Jul 2008
Novartis completes acquisition of 25% stake in Alcon from Nestlé, first step toward majority ownership of the world leader in eye care
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 1 Jul 2008
Bausch & Lomb Names Dr. John W. Sheets, Jr., as Corporate Vice President and Chief Technology Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 24 Jun 2008
Advanced Medical Optics Enters into Cross-Licensing Patent Agreement with Alcon
Devices Ophthalmology Licensing
 HSMN NewsFeed - 24 Jun 2008
Alcon Enters Into Patent Cross-Licensing Agreement With AMO
Devices Ophthalmology Licensing
 HSMN NewsFeed - 17 Apr 2008
Synergetics USA, Inc. Initiates Antitrust Lawsuit against Alcon, Inc.
Devices Ophthalmology Litigation
 HSMN NewsFeed - 15 Apr 2008
Alcon's PATANASE(R) Nasal Spray Approved by FDA for Treatment of Nasal Allergy Symptoms
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Apr 2008
Robert Palmisano Appointed President, Chief Executive Officer and Director of ev3 Inc.
Devices Interventional Personnel
 HSMN NewsFeed - 7 Apr 2008
Novartis to further strengthen its healthcare portfolio by acquiring 25% stake in Alcon from Nestlé with right to take over majority ownership of the world leader in eye care
Biopharmaceuticals Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 10 Mar 2008
Alcon Announces Leadership Change to Research and Development Organization
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 22 Jan 2008
NovaBay Pharmaceutical's Investigational New Drug Application (IND) for the Prevention of Catheter Associated Urinary Tract Infections Cleared by FDA
Biopharmacuticals
 HSMN NewsFeed - 14 Jan 2008
John Moore Appointed to STAAR Surgical Board Of Directors
Devices Ophthalmology Personnel
 HSMN NewsFeed - 5 Dec 2007
WaveLight's VP of Sales to Oversee Marketing
Devices Ophthalmology Personnel
 HSMN NewsFeed - 28 Nov 2007
Barry G. Caldwell Named Chief Executive Officer of STAAR Surgical
Devices Ophthalmology Personnel
 HSMN NewsFeed - 26 Nov 2007
SV Life Sciences Adds Medical Device Executive to MedTech Team
Venture Capital
 HSMN NewsFeed - 6 Nov 2007
Alcon Gains All Regulatory Clearances for Acquisition of WaveLight AG
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 3 Oct 2007
Cellectar Expands Clinical Management Team
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Sep 2007
Alcon Gains 76.9 Percent of WaveLight Shares and Will Move Forward with Acquisition
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 24 Sep 2007
Alcon Receives FDA Decision on RETAANE(R) Suspension for Wet AMD
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 21 Sep 2007
Stiefel Laboratories Appoints Two New Members to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Sep 2007
Alcon Waives Minimum Acceptance Condition for WaveLight AG
Devices Ophthalmology Mergers & Acquisitions
 HSMN NewsFeed - 10 Sep 2007
Alcon Announces Expansion of Swiss Operations
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 26 Jun 2007
Jacqualyn Fouse to Leave Alcon for New Position
Biopharmaceuticals Devices Personnel
 HSMN NewsFeed - 14 Jun 2007
STAAR Surgical Creates New Leadership Position to Oversee Research, Development and Clinical Activities
Devices Ophthalmology Personnel
 HSMN NewsFeed - 12 Jun 2007
Mark J. Forchette Named President and Chief Executive Officer of OptiMedica(R)
Devices Ophthalmology Personnel
 HSMN NewsFeed - 17 May 2007
Ascent Healthcare Receives 510(k) Clearance on Alcon MACKOOL Phaco Tips
Devices Ophthalmology FDA
 HSMN NewsFeed - 10 Apr 2007
Bernard Haffey Appointed President and CEO of NDO Surgical
Devices Gastroenterology Personnel Venture Capital
 HSMN NewsFeed - 29 Mar 2007
Ric Tiplady Joins WaveLight as VP of Business Development
Devices Ophthalmology Personnel
 HSMN NewsFeed - 21 Feb 2007
NovaCal Pharmaceuticals Has Changed Its Name to NovaBay Pharmaceuticals
Biopharmaceuticals
 HSMN NewsFeed - 1 Feb 2007
Alcon's AcrySof(R) ReSTOR(R) Apodized Diffractive Aspheric Intraocular Lens Approved by FDA
Devices Ophthalmology FDA
 HSMN NewsFeed - 24 Jan 2007
CMS Ruling Could Make STAAR Surgical Company Astigmatism-Correcting Lens More Accessible to Medicare Patients
Devices Ophthalmology Reimbursement
 HSMN NewsFeed - 21 Sep 2006
Alcon's TRAVATAN(R) Z Solution Approved by FDA for Treatment of Glaucoma and Ocular Hypertensive Patients
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 18 Sep 2006
Alcon Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections from NovaCal
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 18 Sep 2006
NovaCal Licenses Novel Anti-Infective Compounds for Eye, Ear and Sinus Infections to Alcon
Biopharmaceuticals Ophthalmology Licensing
 HSMN NewsFeed - 21 Jul 2006
Lilly and Alcon Sign Marketing Collaboration for Potentially the First Oral Medication for Diabetic Retinopathy
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 10 Jul 2006
Advanced Medical Optics Announces Settlement With Alcon of Patent Infringement Suits
Devices Ophthalmology Litigation
 HSMN NewsFeed - 10 Jul 2006
Alcon and Advanced Medical Optics Settle All Pending Patent Litigation
Devices Ophthalmology Litigation
 HSMN NewsFeed - 8 May 2006
Alcon Gains FDA Approval for LADAR6000(TM) Excimer Laser and Wavefront-Guided Hyperopia
Devices Ophthalmology FDA
Return to NewsFeed  

 Additional items found! 38

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 38 additional stories matching:
Alcon
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!